Summit Therapeutics (SMMT) Skyrockets on Cancer Breakthrough – Key Facts & Outlook
SMMT Stock’s Wild Ride in 2025 Summit Therapeutics’ share price has been on a roller-coaster ride this year. After a steady climb through late summer, SMMT spiked above $25 intraday in mid-October,